Screening for Breast Cancer¶
U.S. Preventive Services Task Force. (2016). Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 164(4), 279-296.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Asymmetric Screening
- In medical screening it is mammography, PSA testing, lateral-flow tests, and prenatal screening, all designed for high sensitivity at the cost of specificity, with downstream diagnostic follow-up resolving the false positives.
This sourceDocuments screening mammography deliberately tuned for high sensitivity over specificity, with diagnostic workup resolving the false positives the screen admits.
- In medical screening it is mammography, PSA testing, lateral-flow tests, and prenatal screening, all designed for high sensitivity at the cost of specificity, with downstream diagnostic follow-up resolving the false positives.
Verification¶
Does it exist? Confirmed. This work's DOI resolves to a registered record, which fixes its identity. That is all it fixes.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:8bf0870db9ae · see in the full table